Geode Capital Management LLC Has $1.26 Million Stock Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Geode Capital Management LLC increased its stake in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 6.5% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 462,128 shares of the company’s stock after buying an additional 28,323 shares during the period. Geode Capital Management LLC’s holdings in KORU Medical Systems were worth $1,262,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. XTX Topco Ltd acquired a new position in shares of KORU Medical Systems during the third quarter worth approximately $34,000. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in KORU Medical Systems by 77.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after buying an additional 26,860 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in KORU Medical Systems in the 2nd quarter valued at $107,000. Finally, Meros Investment Management LP increased its stake in shares of KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after buying an additional 137,918 shares during the period. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Price Performance

KORU Medical Systems stock opened at $4.00 on Friday. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $183.35 million, a P/E ratio of -16.00 and a beta of 0.45. The business has a 50-day moving average of $3.67 and a 200-day moving average of $2.92. KORU Medical Systems, Inc. has a 1 year low of $1.98 and a 1 year high of $4.60.

Analysts Set New Price Targets

Several equities analysts recently issued reports on KRMD shares. Craig Hallum raised their price target on KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Canaccord Genuity Group raised their target price on shares of KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Piper Sandler boosted their price target on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research note on Thursday, November 14th.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.